Journal of Biomedical Nanotechnology


	Instructions for Authors

	Journal of Biomedical Nanotechnology (JBN) is an interdisciplinary peer-reviewed journal focused on all aspects of nanoscale research in the fields of nanobiotechnology, medicine, biology, biomaterials, biomedical devices, and applications of nanotechnology in all fields of life sciences. JBN publishes original full papers and timely state-of-the-art reviews with author's photo and biography, and short communications encompassing the fundamental and applied research aspects.

	JOURNAL POLICY: It is journal policy to publish only original and unpublished research work therefore Journal of Biomedical Nanotechnology does not wish to receive any papers on research work that has already been reported in parts or contains already published text, data, figures, tables or other illustrations or any copyright materials whatsoever that has been submitted or accepted for publication either in a journal or conference proceedings elsewhere in any form, in print or in electronic media. When submitting a manuscript, authors should make a full statement to the Editor-in-Chief or Editors that the research work contained in their manuscript is completely original and unpublished. If redundant or duplicate publication is attempted or occurs authors should expect immediate editorial action to be taken including prompt rejection of the submitted manuscript. Submission of any manuscript that contains redundant or duplicate publication of the same or very similar research work violates the policies of this journal.

	SUBMISSION OF MANUSCRIPT: Authors are kindly advised to read Journal of Biomedical Nanotechnology policy and also the uniform requirements for manuscripts submitted to Biomedical Journals as proposed by the International Committee of Medical Journal Editors (http://www.icmje.org) before submitting their manuscript to Editor-in-Chief or Editors. Authors are encouraged to submit high quality original research work that has not been published or nor under consideration by other journals or conference proceedings elsewhere. Authors should submit manuscript electronically either as a PDF or Microsoft Word file to the Editor-in-Chief, or to the European Editor, or to the Asian Editor, or to the Associate Editor. Authors are highly encouraged to submit manuscript electronically to save time for the reviewing process.

	EDITOR-IN-CHIEF M. N. V. Ravi Kumar Professor of Drug Delivery Strathclyde Institute of Pharmacy and Biomedical Sciences University of Strathclyde Glasgow, G4 0NR, UK Phone: +44-141-548-5948 Fax: +44-141-552-2562 Email: jbn-mnv@strath.ac.uk
	EUROPEAN EDITOR T. Schalkhammer Max Perutz Laborartories Department of Biochemistry University of Vienna Dr. Bohrgasse 9 A-1030 Vienna, AUSTRIA Email: Thomas.Schalkhammer@univie.ac.at
	ASIAN EDITORS I. C. Kwon Biomedical Research Center Korea Institute of Science and Technology Seoul, SOUTH KOREA E-mail: ikwon@kist.re.kr A. Mittal Department of Biochemical Engineering & Biotechnology Indian Institute of Technology Delhi New Delhi 110016, INDIA E-mail: aditya@dbeb.iitd.ernet.in H.-W. Sung Department of Chemical Engineering National Tsing Hua University Hsinchu 30013, TAIWAN E-mail: hwsung@che.nthu.edu.tw
	ASSOCIATE EDITORS S. G. Antimisiaris, GREECE E-mail: S.Antimisiaris@upatras.gr N. Ashammakhi, FINLAND E-mail: nureddin.ashammakhi@tut.fi M. J. Blanco-Prieto, SPAIN E-mail: mjblanco@unav.es P. Caliceti, ITALY E-mail: paolo.caliceti@unipd.it S. Chen, USA E-mail: scchen@mail.utexas.edu Y. C. Chen, TAIWAN E-mail: yuchie@mail.nctu.edu.tw M. M. De Villiers, USA E-mail: mmdevilliers@pharmacy.wisc.edu S. Kawakami, JAPAN E-mail: kawakami@pharm.kyoto-u.ac.jp R. Löbenberg, CANADA E-mail: rloebenberg@pharmacy.ualberta.ca D. Luo, USA E-mail: DL79@cornell.edu S. M. Moghimi, UK E-mail: momo@farma.ku.dk O. P. Pillai, USA E-mail: omathanu.perumal@sdstate.edu E. Prenner, CANADA E-mail: eprenner@ucalgary.ca C. Prestidge, AUSTRALIA E-mail: prestidge@unisa.edu.au I. Rubinstein, USA E-mail: IRubinst@uic.edu S. Senel, TURKEY E-mail: ssenel@hacettepe.edu.tr G. A. Silva, USA E-mail: gsilva@ucsd.edu

	Authors should submit a list of FIVE (5) potential referees accompanied with their complete mailing address, telephone, fax and email address, who may be contacted for reviewing the manuscript though refereeing, is done by anonymous reviewers. In order to ensure that the highest quality manuscripts are published, reviewing process is carried out in two stages. A mandatory editor's approval is required in the first stage for the manuscripts before it is submitted to the peer review process in the second stage.

	COMMUNICATIONS: Highest priority will be given to the communications reporting important new scientific and technological findings. Rapid publication is provided for concise and up-to-date reports. These articles should not exceed three-four published pages. No section headings should be used for these short communications.

	RESEARCH ARTICLES: Full length papers that report original research work on new ideas in the fields of biomedical nanotechnology.

	REVIEWS: The state-of-the-art review articles with author's short biography and photo will be published. Reviews are limited to a maximum length of 30 journal pages. It is author's responsibility to obtain written copyright permissions to reproduce any copyright materials from other sources. Authors are advised to cite proper references in figure/tables captions of all previously published figures/tables/illustrations including their own published work and obtain copyright permissions from appropriate publishers and authors.

	TYPING: All manuscripts must be in English, typed double-spaced on one side of the page throughout (including footnotes, references, tables, legends) on 8.5" x 11" or A4 white paper leaving at least 1 inch left hand margin.

	INTRODUCTORY MATERIAL: The first page of the manuscript should have a concise title limited to about 15 words and the names of all authors, complete mailing address for correspondence, telephone, fax numbers and email address. Please indicate with an asterisk (*) the author to whom correspondence regarding the manuscript should be directed.

	ABSTRACT: All manuscripts must contain an informative 100 to 250 words abstract explaining the essential contents of the work, key ideas and results.

	KEYWORDS: A list of 5-10 "Keywords" should be included with the abstract.

	GRAPHICAL ABSTRACT: JBN requires Graphic for the Table of contents (GTC) and it must be supplied with each manuscript. This graphical abstract is to be prepared in such a way that it gives the reader an overview of the contents in the manuscript. The graphical abstract should also have the title of the manuscript and list of all authors. The size of the graphical abstract should be limited to within a space of 10 x 4 cm. A typical template for the GTC is given below.



	MAIN AUTHOR'S BIOGRAPHICAL SKETCH (FOR REVIEW ARTICLES ONLY): JBN publishes author's biographical sketch for the review articles. Prepare the sketch based on the following template.



	FIGURES: It is very important to supply high quality figures in a form suitable for reproduction. All figures, tables, illustrations, photographs should be prepared in such a way that they could be printed in a single column size with a width of 3 1/4 inches or 8.25 cm. Only if absolutely necessary should figures/tables/photos occupy double columns. Each figure must be referred to in the text and will be printed in black and white unless otherwise instructed by the authors. Each Figure should be submitted on a separate sheet and marked with the name of the author, title of manuscript and figure number. All formulae and figures should be carefully drafted and never drawn freehand. Use same font and size for all figure legends. High quality original figures and glossy prints of all photographs are required. Photocopies of the figures and photographs are not acceptable. Use 12 font for numbering and 14 font for legends.

	FREE COLOR PRINTING: Color illustrations are most welcome by the journal as they are effective in conveying complex graphs and photographs. Free color printing at the Editor-in-Chief's discretion, will provide an opportunity to publish color figures/illustrations in print at NO COST to the authors.

	PHOTOGRAPHS: Half-tone illustrations should be supplied as clear, glossy, unmounted prints. The author's name, title of manuscript and figure number should be written on the back.

	TABLES: Each table must be referred to in the text. Each table should be typed double-spaced on a separate sheet and identified sequentially by Arabic numerals corresponding to the order in which they appear in the text. Each table should have a brief explanatory title, which should be labeled unambiguously. The position of each table should be clearly marked in the text.

	UNITS: Internationally accepted units of measurement must be used. The units of measurement are used in conjunction with their numerical values; the units should be abbreviated as suggested below. If more commonly used units are adopted, conversion factors should be given at their first occurrence. Greek symbols may be used. %, ÂºC, nm, Âµm (not m), mm, cm, cm3, m, h (or hr), min, s (or sec), Âµg, mg, g (or gm), kg, cal, kcal, in. (or write out inch), ml [write out liter(s)].

	The APS style guide can be used as a general reference on matter of units, grammar and formatting.

	ABBREVIATIONS: No abbreviations are allowed in the title and abstract and should be defined the first time they are used within the text. The "Journal of Biomedical Nanotechnology" should be abbreviated as J. Biomed. Nanotech. for the citation purpose. .

	REFERENCES: References should be in the proper format on a separate page, numbered in the sequence in which they occur in the text. Cite the references in the text as Arabic numbers in one consecutive series by the order of appearance in the text, with the text citations presented as unparenthesized superscripts. Include the title of the article in the cited reference. References should be listed in the following style:

	1. Journal Article J. Davda, V. Labhasetwar, Sustained activity of vascular endothelial growth factor following encapsulation in nanoparticles., J. Biomed. Nanotechnol. 1, 74-82 (2005). J. M. Koziara, P. R. Lockman, D. D. Allen, and R. J. Mumper, The Blood-Brain Barrier and Brain Drug Delivery, J. Nanosci. Nanotechnol. 6, 2712–2735 (2006) 2. Book H. S. Nalwa, Editor, Handbook of Nanostructured Biomaterials and Their Applications in Nanobiotechnology, Vol. 1-2, American Scientific Publishers, Los Angeles (2005) 3. Chapter in a Book T. Schalkhammer, in Encyclopedia of Nanoscience and Nanotechnology, Edited H. S. Nalwa, American Scientific Publishers, Los Angeles (2004), Vol. 1, pp.329-360. 4. Conference Proceedings J. Kimura and H. Shibasaki, Editors. Recent advances in clinical neurophysiology. Proceedings of the 10th International Congress of EMG and Clinical Neurophysiology, (1995) October 15-19; Kyoto, Japan 5. Patent C. E. Larsen, R. Trip, and C.R. Johnson, Methods for procedures related to the electrophysiology of the heart. U.S. Patent 5,529,067, Jun 25 (1995).

	Do not use the phrases "et al." and "ibid." in the reference section. Instead, the names of all authors in a reference must be listed.

	ACKNOWLEDGEMENTS: These should be brief and placed at the end of the text before the references.

	PROOFS: Page proofs for the correction of printer's errors only will be dispatched to the corresponding author denoted with an asterik (*) unless otherwise requested. Alterations at this stage are not allowed as they are expensive and may have to be charged to the authors. The proofread copy and reprint order form must be returned within 72 hours.

	OFFPRINTS: Authors may order reprints of articles with a minimum of 100 from ASP prior to publication. An order form accompanying the page proofs will be sent directly to the author. Please return your reprint order form with the page proofs.

	ELECTRONIC SUBMISSION: Upon acceptance of the manuscript for publication, authors should submit to the publisher a diskette or CD containing the final version of the manuscript accompanied by a hard copy printout to improve the accuracy and speed up the typesetting process. The disk or CD should be clearly labeled with the author's name, manuscript title, the date, and the hardware and software package used in preparation. The preferred medium is 3.5-inch diskette or a CD in Windows/MS-DOS or Macintosh having TeX. We are also able to accept line artwork/graphics on disk or CD if you supply us the source files to enables us to modify the artwork as required for the journal format.

	REFEREEING: If you are interested in reviewing the manuscripts for JBN, please send 15-20 keywords in the field of your research expertise, your short biography and your complete mailing address, phone, fax and email address to the Editor. Reviewer's report can be submitted by e-mail to the Editor-in-Chief at jbn-mnv@strath.ac.uk or by fax at +44-141-552-2562. To speed up the reviewing process, editors will communicate with authors and the referees via email. ASP or Editors will not return manuscripts to authors and keep any records whatsoever after a formal decision has been made about the manuscript. Editors have the right to reject the manuscript.

	COPYRIGHT: All authors are responsible for the complete contents of their manuscript. The author(s) warrant that the work contains no unlawful or libelous statements and opinions and liable materials of any kind whatsoever, do not infringe on any copyrights, intellectual property rights, personal rights or rights of any kind of others, and contain any materials, instructions, procedures, information or ideas that might cause any harm, damage, injury, losses or costs of any kind to person or property. It is authors' responsibility to obtain written copyright permissions from other sources for reproduction of any figures, tables, photos, illustrations, text or other copyright materials from previously published work. It is the policy of American Scientific Publishers to own the copyright of all contributions it publishes. To comply with the U.S. Copyright Law, a Copyright Transfer Form that transfer copyright of the article to the publisher must be completed by the authors prior to publication of an accepted article in this journal. Authors must submit a signed copy of this form with their manuscript.

	Terms and Conditions Privacy Policy Copyright © 2000-2008 American Scientific Publishers. All Rights Reserved.